The murine Lewis lung carcinoma is a longterm grafted tumor that, after subcutaneous inoculation, forms metastases to the lungs. Forty-two cell lines were established from a primary tumor site and 40 were established from lung metastatic foci. Cloned sublines were established from the original 82 lines, and 2 sublines among 405 were found to be tumorigenic but not metastatic (T+/M-), whereas the remaining 403 sublines were both tumorigenic and metastatic (T+/M+). The Gene expression is influenced by a variety of biological mechanisms that are only partly known (1-6). It has become increasingly evident, however, that enzymatic methylation of cytosine to 5-methylcytosine (m5Cyt) is an important gene silencing factor (7-10) in regard to both cellular (11-14) and viral (15) (16) (17) genes. This has been substantiated by the fact that demethylation of DNA as obtained by replacement of cytosine with 5-azacytidine (5-azaC) may result in expression of otherwise silent genes in a number of biological systems (18) (19) (20) (21) (22) , although the biological details still are unknown (5, 6).
sion of otherwise silent genes in a number of biological systems (18) (19) (20) (21) (22) , although the biological details still are unknown (5, 6) .
Metastatic spread of neoplasms is presumably based on multiple genetic and epigenetic features that are expressed by at least some of the tumor cells (23) (24) (25) (26) . It is also conceivable that the metastatic phenotype is determined by different gene products in different tumors. It is therefore important to clarify whether metastatic activity can be induced solely by alteration in activity of preexisting genes in nonmetastatic tumor cells.
We report here that the metastatic phenotype can be expressed by otherwise stable nonmetastatic mouse tumor cells after demethylation of DNA of proliferating tumor cells with 5-azaC. Metastatic cells could be identified by a monoclonal antibody (mAb) that recognized an epitope specifically expressed on metastatic cells. The same antibody was found to react with a cellular protein of Mr 45,000 and pl 6.7 and two slightly more acidic proteins, which may be modifications of the former.
MATERIALS AND METHODS

Establishment of Cell Lines and Subclones of the Lewis
Lung Carcinoma (3LL). Cell lines were established from s.c. growing primary 3LL tumor lesions and from metastatic foci as described in detail elsewhere (27) . Biopsies from such tumor lesions were seeded into plastic flasks as explant cultures in RPMI 1640 medium with 15% fetal calf serum. After 3-6 weeks in liquid medium, the cultures were cloned in semisolid 0.3% agar RPMI 1640 medium with 10% fetal calf serum. Clones were harvested from the agar cultures and expanded and maintained in liquid RPMI 1640 medium with 10% fetal calf serum. One cloned culture from each biopsy of either primary tumor lesions or metastatic foci was used to establish subclones. All cell lines were maintained in plastic flasks in RPMI 1640 medium with 10% fetal calf serum/0.3% L-glutamine at 370C in a humidified atmosphere with 5%
CO2. The cells grew as adherent cultures with cell population doubling times of 20-25 hr in the exponential growth phase. The cells were seeded at a concentration of 2 x 104 cells per cm2 and were split at a density of 2-4 x 105 per cm2; these numbers were used to estimate the number of population doublings (see Table 4 ).
The original cultures were cloned in 0.3% semisolid agar RPMI 1640 medium with 15% fetal calf serum, and subclones were established from such cultures by harvesting individual colonies with subsequent expansion in liquid medium. Five subclones were established from each culture. All subclones had in vitro growth properties comparable to the original cultures.
The cells were treated with 5-azaC by growing the cultures for 3 days in RPMI 1640 with 15% fetal calf serum supplemented with 3 ,M 5-azaC, washed twice in phosphate-buffered saline, cultivated for another 10 days in conventional RPMI 1640 medium with 15% fetal calf serum, and then injected s.c. in a dose of 1-5 x 107 into C57BL/6 mice.
Tumorigenicity and Metastatic Activity. Tumorigenic activity (T+) was estimated by injection of 0.01-5 x 107 cells s.c. into 4-to 8-week-old C57BL/6 mice. Three to 10 mice were used to assay for tumorigenic activity of each cell line. It was concluded that a given line was nontumorigenic (T-) if injection of 5 x 107 cells did not result in tumors up to 4 months after tumor-cell grafting. Thus, 2 of the 208 sublines from cultures of primary tumor lesions did not result in tumors on s.c. injection into 20 mice (10 mice for each line). (29) . The pellet was solubilized in lysis buffer containing 1% NaDodSO4, heated for 3 min at 70°C, and polypeptides were separated by two-dimensional gel electrophoresis (30) . The gels were treated with 2,5-diphenyloxazole, dried, and fluorography was carried out for 2 months at -80°C.
RESULTS
Cell lines were established from primary s.c. growing 3LL tumor lesions and from individual lung metastases (Table 1 when moribund, all animals were examined for lung metastases). The T and M features of the six metastatic sublines were tested every 2-3 months and have been stable >2 yr. In addition, we attempted to generate murine mAbs binding to antigens associated with expression of the malignant phenotype. One antibody M36D3 with such specificity was obtained (Table 1) .
Forty-five randomly selected T+/M+ lines (23 from primary tumor lesion and 22 from metastatic foci) were treated with 5-azaC. Two lines lost both their in vivo tumorigenic and metastatic activity but retained their in vitro growth capability, 17 lost the metastatic phenotype, and 26 clones were unchanged after 5-azaC treatment. The same T and M properties were observed for all clones on inoculation into athymic nude C57BL/6 mice (data not shown). Expression of H-2 antigens was unaltered in all lines as tested by FACS with a polyclonal allogenic antibody against H-2b (data not shown). Loss of metastatic activity co-varied with loss of expression of the epitope for the M36D3 antibody as detected by FACS (Table 2) .
5-azaC treatment of 30 T+/M-subclones established from the original 2 T+/M-clones resulted in expression of metastatic activity in 11 subclones, 3 clones became T-/M-, and 16 clones were unchanged T+/M-. Again, the same T-and M-features were observed on inoculation into athymic nude C57BL/6 mice. However, whereas the original 3LL murine tumor selectively metastasizes to the lungs, the clones expressing metastatic behavior only after 5-azaC treatment formed metastases not only in the lungs but also in some cases in the liver and in the spleen. It is noteworthy that liver and spleen metastases were not observed after 5-azaC treatment of cells that originally expressed the metastatic phenotype prior to treatment (Table 3) . All (Fig. 1, arrowheads) . These spots were due to unspecific precipitation with the Sepharose beads, because they were present in precipitates from all four cell types, regardless of type of mAb or whether the Sepharose contained protein A. DNA methylation of the lines was also measured prior to 5-azaC treatment and at various time intervals afterward (Table 5 ). Most 5-azaC-treated clones were hypomethylated compared to nontreated cells. However, two of the five clones that gained and maintained metastatic activity were not hypomethylated.
DISCUSSION
The genetic basis for tumorigenicity is currently studied by transforming preneoplastic mouse cells by DNA fragments of malignant cells of both animal and human origin (33-36). (in contrast to most other studies that have used high and low metastatic cell lines) in the 3LL system shows that at least a part of the genetic basis for metastatic activity differs from that for tumorigenicity. Our tumor model should, therefore, enable us to further identify these genes.
5-azaC is incorporated at multiple sites into the DNA and may also lead to demethylation at the level of the hemimethylases (37). It is, therefore, likely that a multitude of genes irrelevant for metastatic activity are demethylated. Consequently, the total amount of m5Cyt cannot be used to evaluate the role of m5Cyt in regulation of expression of genes relevant for metastatic activity. A number of cell lines reversed after a variable number of cell divisions to the phenotype observed prior to 5-azaC treatment. The enzymatic DNA methylation pattern in this system was, therefore, not strictly heritable, in line with reports in other cell systems (14, 38, 39) .
5-azaC is not (or only negligibly) mutagenic (40) in the doses used in this study. This was recently substantiated by the observation (unpublished data) that 5-azaC in doses <8
,uM did not induce any increase in the number of ouabain-or 6-thioguanine-resistant cell variants of the 3LL line, a human B-lymphoma line, a human squamous lung carcinoma line, Table 4 . Tumorigenic and metastatic activity of 3LL sublines at various time intervals after they were altered in their T/M features by 5-azaC (Fig. 1, small arrows) Intratumoral phenotypic diversity of malignant neoplasms has been shown with respect to a number of biological features, including those for metastasis (23) . The biological basis for this diversity is unknown, but it can be assumed to be a result of a number of genetic and epigenetic mechanisms. The present results show that the phenotypic diversity, at least in part, can be obtained solely by alteration of the enzymatic DNA methylation pattern and support the idea that the phenotypic features of a tumor cell population are continuously subject to change (42) (43) (44) .
